Abstract:. AJ1-11095, a type II JAK2 inhibitor being developed for myelofibrosis, led to impressive clinical responses in a recent phase I study, suggesting that the drug, and perhaps the rest of its ...
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD- Deleted Cancers
This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...
To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...
You do not currently have access to this content.
Copyright held by the owner/author(s).
Although antibody–drug conjugates (ADC) have transformed the standard of care for patients with metastatic urothelial carcinoma, primary and acquired resistance remain major obstacles to achieving ...
Abstract. Glucocorticoid receptor (GR) signaling is critical to our physiology but is dysregulated in cancer by the pain, psychologic distress, iatrogenic morbidity, and pathology associated with an ...
Cancer Discov (2026) 16 (7): OF1.
Cancer Discov (2026) 16 (7): OF1.
Cancer Discov (2026) 16 (7): OF1.
Cancer Discov (2026) 16 (7): OF1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results